Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-16

FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for ALENDRONATE SODIUM tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., enabling a generic alendronate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alendronate Sodium Tablet (Alendronate sodium)

Snippet

SUPPL AP for ALENDRONATE (ALENDRONATE SODIUM)